A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens (Q44477679)

3 December 2017

title

A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens (English)

1 reference

3 December 2017

0 references

Anke Richter

1

1 reference

3 December 2017

Brett Hauber

2

1 reference

3 December 2017

Kit Simpson

3

1 reference

3 December 2017

Josephine A Mauskopf

4

1 reference

3 December 2017

Dongping Yin

5

1 reference

3 December 2017

publication date

1 January 2002

1 reference

3 December 2017

1 reference

3 December 2017

volume

20

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

215-224

1 reference

Updates of Cost of Illness and Quality of Life Estimates for Use in Economic Evaluations of HIV Prevention Programs

3 December 2017

cites work

1 reference

12 December 2020

Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning

1 reference

12 December 2020

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection

1 reference

12 December 2020

Progressive CD4 cell depletion and death in zidovudine-treated patients

1 reference

12 December 2020

Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens

1 reference

12 December 2020

The cost effectiveness of combination antiretroviral therapy for HIV disease.

1 reference

12 December 2020

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy

1 reference

12 December 2020

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

1 reference

12 December 2020

Immune restoration with antiretroviral therapies: implications for clinical management

1 reference

12 December 2020

Re: "Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts".

1 reference

12 December 2020

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection

1 reference

12 December 2020

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

1 reference

12 December 2020

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

12 December 2020

The natural history of HIV-1 infection: staging classifications of disease.

1 reference

12 December 2020

Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359.

1 reference

12 December 2020

Design and assessment of cost-effectiveness studies in AIDS populations

1 reference

12 December 2020

10.2165/00019053-200220040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

1045170189

0 references

1 reference